-
1
-
-
0031918203
-
Tumor necrosis factor in the heart
-
DR. Meldrum Tumor necrosis factor in the heart Am J Physiol 274 1998 R577 R595
-
(1998)
Am J Physiol
, vol.274
, pp. R577-R595
-
-
Meldrum, DR.1
-
3
-
-
0029896491
-
Preventing the inflammatory response to open heart surgery: the role of aprotinin and other protease inhibitors
-
D. Royston Preventing the inflammatory response to open heart surgery: the role of aprotinin and other protease inhibitors Int J Cardiol 53 Suppl 1996 S11 S37
-
(1996)
Int J Cardiol
, vol.53
, Issue.Suppl
, pp. S11-S37
-
-
Royston, D.1
-
4
-
-
0026001532
-
Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion
-
M Sunamori I Sultan A. Suzuki Effect of aprotinin to improve myocardial viability in myocardial preservation followed by reperfusion Ann Thorac Surg 52 1991 971 978
-
(1991)
Ann Thorac Surg
, vol.52
, pp. 971-978
-
-
Sunamori, M1
Sultan, I2
Suzuki, A.3
-
5
-
-
0028972012
-
Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass–induced inflammation in humans
-
GE Hill A Alonso JR Spurzem AH Stammers RA. Robbins Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass–induced inflammation in humans J Thorac Cardiovasc Surg 110 1995 1658 1662
-
(1995)
J Thorac Cardiovasc Surg
, vol.110
, pp. 1658-1662
-
-
Hill, GE1
Alonso, A2
Spurzem, JR3
Stammers, AH4
Robbins, RA.5
-
6
-
-
0031902013
-
Aprotinin reduces nitric oxide production in vitro and in vivo in a dose-dependent manner
-
NL Bruda BJ Hurlbert GE. Hill Aprotinin reduces nitric oxide production in vitro and in vivo in a dose-dependent manner Clin Sci 94 1998 505 509
-
(1998)
Clin Sci
, vol.94
, pp. 505-509
-
-
Bruda, NL1
Hurlbert, BJ2
Hill, GE.3
-
7
-
-
0024239087
-
Clinical and biochemical applications of luciferases and luciferins
-
LJ. Kricka Clinical and biochemical applications of luciferases and luciferins Anal Biochem 175 1988 14 21
-
(1988)
Anal Biochem
, vol.175
, pp. 14-21
-
-
Kricka, LJ.1
-
8
-
-
0030198549
-
Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion
-
J Gurevitch I Frolkis Y Yuhas Y Paz M Matsa R Mohr Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion J Am Coll Cardiol 28 1996 247 252
-
(1996)
J Am Coll Cardiol
, vol.28
, pp. 247-252
-
-
Gurevitch, J1
Frolkis, I2
Yuhas, Y3
Paz, Y4
Matsa, M5
Mohr, R6
-
9
-
-
0028298296
-
Pharmacokinetics of aprotinin in preoperative cardiac surgical patients
-
JH Levy JM Bailey M. Salmenpera Pharmacokinetics of aprotinin in preoperative cardiac surgical patients Anesthesiology 80 1994 1013 1018
-
(1994)
Anesthesiology
, vol.80
, pp. 1013-1018
-
-
Levy, JH1
Bailey, JM2
Salmenpera, M.3
-
11
-
-
0026443864
-
Cyclosporin A metabolism in human liver, kidney, and intestine slices: comparison to rat and dog slices and human cell lines
-
AEM Vickers V Fischer S Connors RL Fisher JP Baldek G Maurer Cyclosporin A metabolism in human liver, kidney, and intestine slices: comparison to rat and dog slices and human cell lines Drug Metab Dispos 20 1992 802 809
-
(1992)
Drug Metab Dispos
, vol.20
, pp. 802-809
-
-
Vickers, AEM1
Fischer, V2
Connors, S3
Fisher, RL4
Baldek, JP5
Maurer, G6
-
12
-
-
0027960498
-
Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals
-
AEM. Vickers Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals Cell Biol Toxicol 10 1994 407 414
-
(1994)
Cell Biol Toxicol
, vol.10
, pp. 407-414
-
-
Vickers, AEM.1
|